Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Non-Randomised Controlled Study of the Safety, Performance, Quality of Life and Cost Effectiveness Outcomes of the Edwards SAPIEN XT™ Transcatheter Heart Valve in an Australian Population

NCT01675596 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT01675596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01675596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Non-Randomised Controlled Study of the Safety, Performance, Quality of Life and Cost Effectiveness Outcomes of the Edwards SAPIEN XT™ Transcatheter Heart Valve in an Australian Population
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2012
Completion date
August 8, 2018
Enrollment
199 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

severe, symptomatic aortic stenosis